Regenicin, Inc. (RGIN) financial statements (2022 and earlier)
Company profile
| Business Address |
10 HIGH COURT LITTLE FALLS, NJ 07424 |
| State of Incorp. | NV |
| Fiscal Year End | September 30 |
| SIC | 3841 - Surgical and Medical Instruments and Apparatus (benchmarking) |
| More info | Complete financial analysis Financial benchmarking |
Balance sheet (Statement of financial position) ($ in thousands)
| 12/31/2021 TTM | 9/30/2021 | 9/30/2020 | 9/30/2019 | 9/30/2018 | |||
|---|---|---|---|---|---|---|---|
| ASSETS | |||||||
| Current Assets | |||||||
| Cash, cash equivalents, and short-term investments | 3 | 4 | 1 | 1 | 3 | ||
| Cash and cash equivalents | 3 | 4 | 1 | 1 | 3 | ||
| Total current assets: | 3 | 4 | 1 | 1 | 3 | ||
| Noncurrent Assets | |||||||
| Other undisclosed assets | 2 | 1 | 3 | 5 | 54 | ||
| TOTAL ASSETS: | 6 | 5 | 4 | 5 | 56 | ||
| LIABILITIES AND EQUITY | |||||||
| Liabilities | |||||||
| Current Liabilities | |||||||
| Accounts payable and accrued liabilities | 4,504 | 4,569 | 3,888 | 3,278 | 2,696 | ||
| Accounts payable | 85 | 94 | 89 | 138 | 68 | ||
| Accrued liabilities | 243 | 235 | 174 | 144 | 231 | ||
| Employee-related liabilities | 4,176 | 4,031 | 3,450 | 2,869 | 2,288 | ||
| Interest and dividends payable | 209 | 174 | 127 | 110 | |||
| Debt | 185 | 185 | 185 | 10 | 10 | ||
| Other undisclosed current liabilities | 428 | 209 | 219 | 445 | 350 | ||
| Total current liabilities: | 5,118 | 4,962 | 4,291 | 3,733 | 3,056 | ||
| Noncurrent Liabilities | |||||||
| Total liabilities: | 5,118 | 4,962 | 4,291 | 3,733 | 3,056 | ||
| Stockholders' equity | |||||||
| Stockholders' equity attributable to parent, including: | (4,287) | (4,958) | (3,728) | (3,728) | (3,000) | ||
| Common stock | 158 | 158 | 158 | 158 | 158 | ||
| Treasury stock, value | (4) | (4) | |||||
| Additional paid in capital | 10,208 | 10,208 | 10,208 | 10,208 | 10,178 | ||
| Accumulated other comprehensive income | 1 | ||||||
| Retained earnings (accumulated deficit) | 15,475 | 15,321 | (14,650) | (14,090) | (13,333) | ||
| Other undisclosed stockholders' equity attributable to parent | (30,124) | (30,640) | 556 | (4) | (4) | ||
| Other undisclosed stockholders' equity | (825) | (560) | |||||
| Total stockholders' equity: | (5,112) | (4,958) | (4,287) | (3,728) | (3,000) | ||
| TOTAL LIABILITIES AND EQUITY: | 6 | 5 | 4 | 5 | 56 | ||
Income statement (P&L) ($ in thousands)
| 12/31/2021 TTM | 9/30/2021 | 9/30/2020 | 9/30/2019 | 9/30/2018 | ||
|---|---|---|---|---|---|---|
| Revenues (Other Operating Income) | 153 | 249 | ||||
| Gross profit: | 153 | 249 | ||||
| Operating expenses | (707) | (636) | (737) | (789) | ||
| Other operating expense, net (Other Expenses) | (15) | (22) | (19) | |||
| Other undisclosed operating income (loss) | 15 | (664) | 22 | 19 | ||
| Operating loss: | (707) | (636) | (511) | (737) | (540) | |
| Nonoperating income (Investment Income, Nonoperating) | 3 | |||||
| Interest and debt expense | 103 | 35 | 106 | (18) | 230 | |
| Net loss: | (602) | (601) | (405) | (755) | (310) | |
| Other undisclosed net income (loss) attributable to parent | (137) | (69) | 965 | 1,513 | (249) | |
| Net income (loss) attributable to parent: | (739) | (671) | 560 | 758 | (559) | |
| Other undisclosed net loss available to common stockholders, basic | (71) | (70) | (1,190) | (1,588) | ||
| Net loss available to common stockholders, diluted: | (809) | (741) | (631) | (829) | (559) | |
Comprehensive Income ($ in thousands)
| 12/31/2021 TTM | 9/30/2021 | 9/30/2020 | 9/30/2019 | 9/30/2018 | ||
|---|---|---|---|---|---|---|
| Net loss: | (602) | (601) | (405) | (755) | (310) | |
| Comprehensive loss: | (602) | (601) | (405) | (755) | (310) | |
| Other undisclosed comprehensive loss, net of tax, attributable to parent | (248) | |||||
| Comprehensive loss, net of tax, attributable to parent: | (602) | (601) | (405) | (755) | (559) | |
Statements sources
The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.